GLP‐1 Is a Coronary Artery Vasodilator in Humans-Reference-Cited by-同舟云学术

GLP‐1 Is a Coronary Artery Vasodilator in Humans

Published:2018-11-20 Issue:22 Volume:7 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:J Am Heart Assoc

Author:

Clarke Sophie J.¹,Giblett Joel P.²,Yang Lucy L.³,Hubsch Annette³,Zhao Tian²,Aetesam‐ur‐Rahman Muhammad²,West Nick E. J.²,O'Sullivan Michael²,Figg Nichola¹,Bennett Martin¹,Wewer Albrechtsen Nicolai J.⁴⁵,Deacon Carolyn F.⁴,Cheriyan Joseph³,Hoole Stephen P.²

Affiliation:

1. Division of Cardiovascular Medicine University of Cambridge United Kingdom

2. Department of Interventional Cardiology Royal Papworth Hospital NHS Foundation Trust Cambridge United Kingdom

3. Division of Experimental Medicine and Immunotherapeutics University of Cambridge United Kingdom

4. Department of Biomedical Sciences NNF Centre for Basic Metabolic Research University of Copenhagen Denmark

5. Department of Clinical Biochemistry, Rigshospitalet University of Copenhagen Denmark

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference41 articles.

1. Are users of sulphonylureas at the time of an acute coronary syndrome at risk of poorer outcomes?

2. Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction

3. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

4. Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure

5. Type 2 diabetes and coronary heart disease: Focus on myocardial infarction

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery Disease;2024-08-16

2. G Protein-Coupled Receptors: A Century of Research and Discovery;Circulation Research;2024-06-21

3. Transforming Diabetes Care: The Molecular Pathways through Which GLP1-RAs Impact the Kidneys in Diabetic Kidney Disease;Biomedicines;2024-03-14

4. Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action;Nature Reviews Cardiology;2023-03-28

5. Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating microRNA-29b-3p/SLMAP;Drug Design, Development and Therapy;2023-03